Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	89.33	55.45	80.34	52.21	101.14	92.8
Short-Term Investments	90.94	188.29	153.72	293.58	53.15	92.98
Cash & Short-Term Investments	180.28	243.75	234.06	345.8	154.29	185.77
Cash Growth	-32.58%	4.14%	-32.31%	124.12%	-16.95%	1140.04%
Receivables	-	-	-	-	300	-
Prepaid Expenses	2.59	5.85	6.12	5.6	5.27	4.92
Restricted Cash	1.25	-	-	-	-	-
Total Current Assets	184.12	249.6	240.18	351.4	459.56	190.69
Property, Plant & Equipment	18.84	32.61	42.91	49.4	56.08	62.33
Other Long-Term Assets	2.01	1.78	2.82	4.09	4.13	2.58
Total Assets	204.96	283.98	285.92	404.88	519.77	255.59
Accounts Payable	3.21	3.79	6.26	5.41	3.82	3.68
Accrued Expenses	9.82	8.53	8.43	11	9.56	6.78
Current Portion of Leases	6.76	9.07	8.52	5.97	6.99	3.98
Current Income Taxes Payable	-	-	0.67	-	-	-
Current Unearned Revenue	65.3	45.61	34.55	32.82	28.32	2.02
Other Current Liabilities	-	-	-	-	-	2.39
Total Current Liabilities	85.09	66.99	58.44	55.21	48.69	18.85
Long-Term Debt	-	-	-	-	-	19.65
Long-Term Leases	15.77	28.06	36.56	45.54	51.34	58.36
Long-Term Unearned Revenue	193.1	234.46	268.12	304	322.73	12.55
Other Long-Term Liabilities	0.66	-	-	0.03	0.14	-
Total Liabilities	294.62	329.51	363.11	404.77	422.9	109.41
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	521.12	512.52	395.2	377.23	361.13	309.13
Retained Earnings	-610.8	-558.18	-471.56	-373.14	-264.26	-162.94
Comprehensive Income & Other	0.02	0.14	-0.83	-3.99	-0.01	-0.01
Total Common Equity	-89.66	-45.53	-77.19	0.11	96.87	146.19
Shareholders' Equity	-89.66	-45.53	-77.19	0.11	96.87	146.19
Total Liabilities & Equity	204.96	283.98	285.92	404.88	519.77	255.59
Total Debt	22.53	37.13	45.07	51.51	58.33	82
Net Cash (Debt)	157.75	206.62	188.98	294.29	95.96	103.77
Net Cash Growth	-30.91%	9.33%	-35.78%	206.69%	-7.53%	-
Net Cash Per Share	2.51	3.76	4.50	7.08	2.58	9.39
Filing Date Shares Outstanding	56.55	55.61	42.57	41.8	41.42	36.82
Total Common Shares Outstanding	56.54	55.59	42.28	41.8	41.3	36.79
Working Capital	99.03	182.61	181.75	296.19	410.87	171.84
Book Value Per Share	-1.59	-0.82	-1.83	0.00	2.35	3.97
Tangible Book Value	-89.66	-45.53	-77.19	0.11	96.87	146.19
Tangible Book Value Per Share	-1.59	-0.82	-1.83	0.00	2.35	3.97
Machinery	9.23	8.03	7.73	6.8	5.8	4.66
Leasehold Improvements	17.02	17.02	17.24	17.12	17.06	16.96

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q